1. Angiotensin Converting Enzyme‐2 Therapy Improves Liver Fibrosis and Glycemic Control in Diabetic Mice With Fatty Liver. Issue 5 (23rd December 2021) Authors: Rajapaksha, Indu G.; Gunarathne, Lakmie S.; Asadi, Khashayar; Laybutt, Ross; Andrikopoulous, Sof; Alexander, Ian E.; Watt, Mathew J.; Angus, Peter W.; Herath, Chandana B. Journal: Hepatology communications Issue: Volume 6:Issue 5(2022) Page Start: 1056 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Liver‐Targeted Angiotensin Converting Enzyme 2 Therapy Inhibits Chronic Biliary Fibrosis in Multiple Drug‐Resistant Gene 2‐Knockout Mice. Issue 12 (10th October 2019) Authors: Rajapaksha, Indu G.; Gunarathne, Lakmie S.; Asadi, Khashayar; Cunningham, Sharon C.; Sharland, Alexandra; Alexander, Ian E.; Angus, Peter W.; Herath, Chandana B. Journal: Hepatology communications Issue: Volume 3:Issue 12(2019) Page Start: 1656 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Mas‐related G protein‐coupled receptor type D antagonism improves portal hypertension in cirrhotic rats. Issue 9 (20th May 2022) Authors: Gunarathne, Lakmie S.; Rajapaksha, Indu G.; Casey, Stephen; Qaradakhi, Tawar; Zulli, Anthony; Rajapaksha, Harinda; Trebicka, Jonel; Angus, Peter W.; Herath, Chandana B. Journal: Hepatology communications Issue: Volume 6:Issue 9(2022) Page Start: 2523 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗